Union Bancaire Privee UBP SA Acquires Shares of 1,910 ARK Genomic Revolution ETF (BATS:ARKG)

Union Bancaire Privee UBP SA bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKGFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,910 shares of the company’s stock, valued at approximately $45,000.

Several other institutional investors and hedge funds have also made changes to their positions in ARKG. JPMorgan Chase & Co. lifted its holdings in ARK Genomic Revolution ETF by 31.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock worth $75,655,000 after buying an additional 698,701 shares in the last quarter. Barclays PLC lifted its stake in shares of ARK Genomic Revolution ETF by 252.7% in the third quarter. Barclays PLC now owns 285,108 shares of the company’s stock worth $7,299,000 after acquiring an additional 204,283 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in ARK Genomic Revolution ETF by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after purchasing an additional 3,341 shares during the last quarter. PFM Health Sciences LP purchased a new stake in ARK Genomic Revolution ETF during the 3rd quarter worth approximately $2,226,000. Finally, Quadrature Capital Ltd acquired a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at approximately $1,970,000.

ARK Genomic Revolution ETF Price Performance

ARKG stock opened at $26.26 on Thursday. The stock’s fifty day moving average is $25.10 and its 200 day moving average is $25.18.

ARK Genomic Revolution ETF Company Profile

(Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

See Also

Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKGFree Report).

Institutional Ownership by Quarter for ARK Genomic Revolution ETF (BATS:ARKG)

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.